These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 470859

  • 1. [Experience with desferrioxamine treatment by intravenous administration, in thalassemia].
    Barcellona R, Masseria R, Palmigiano C, Amato GM.
    Minerva Pediatr; 1979 May 31; 31(10):809-12. PubMed ID: 470859
    [No Abstract] [Full Text] [Related]

  • 2. [Experience with desferrioxamine treatment by slow subcutaneous administration, in thalassemia].
    Barcellona R, Masseria R, Palmigiano C, Amato GM.
    Minerva Pediatr; 1979 May 31; 31(10):805-8. PubMed ID: 470858
    [No Abstract] [Full Text] [Related]

  • 3. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
    Orsini A, Giraud F, Bernard P, Passeron P.
    Mars Med; 1965 May 31; 102(7):591-5. PubMed ID: 5855127
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A, Khalifa AS, Rahman YA, el-Bagoury I.
    J Trop Med Hyg; 1969 Jan 31; 72(1):22-6. PubMed ID: 5773810
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].
    Arnold H, Wehinger H, Deus B, Löhr GW.
    Dtsch Med Wochenschr; 1978 Aug 04; 103(31):1240-4. PubMed ID: 668572
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC.
    Trans Assoc Am Physicians; 1977 Aug 04; 90():335-41. PubMed ID: 611665
    [No Abstract] [Full Text] [Related]

  • 14. Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
    Kontopoulou-Griva I, Hatzidimitriou-Papazacharia K, Spiliotopoulou J, Tsagarakis N, Digenopoulou E.
    Birth Defects Orig Artic Ser; 1988 Aug 04; 23(5B):111-6. PubMed ID: 3390532
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience with desferrioxamine B in the treatment of ocular siderosis (apropos of 6 cases)].
    Paufique L, Bonnet M, Didierlaurent A.
    Bull Soc Ophtalmol Fr; 1966 Sep 04; 66(9):774-81. PubMed ID: 5976428
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.